Tax Reform Passage a Tremendous Win for America’s Workers & Consumers (Arlington, Virginia) — Today CASE – Consumer Action for a […]
BY GERARD SCIMECA, CASE CHAIRMAN — December 18, 2017 http://bit.ly/2B9sbIj Abraham Lincoln said the best way to get a bad law […]
Are You Paying Too Much For Your Prescription? Maybe, But Your Pharmacist Isn’t Allowed To Tell You.
Pharmacy benefit managers (PBMs), which act as intermediaries between pharmaceutical manufacturers, insurers and pharmacies, operate behind the scenes and are […]
Consumer Action for a Strong Economy (CASE) is pleased by today’s FCC’s vote to establish a clear national policy of […]
http://bit.ly/2C2BPII By Matthew Kandrach President, CASE December 13, 2017 With the Senate tax bill passing after an all-night vote-a-rama of handwritten additions and […]
Matthew Kandrach, CASE President – December 13, 2017 http://bit.ly/2iZRtgx When all you have is a hammer, everything looks like a nail […]
Gerard Scimeca, CASE Chairman December 11, 2017 – http://bit.ly/2AbxGBC With the recent $69 billion acquisition of Aetna insurance by CVS — […]
MORNING CONSULT – December 11, 2017 Matthew Kandrach, CASE President https://bitly.is/1g3AhR6 The holiday shopping season is here, replete with “Black […]
Americans have diverse opinions on what the federal government’s role in the healthcare sector should be, but almost everyone agrees […]
http://bit.ly/2EsfFSE Matthew Kandrach, CASE President Government programs don’t have a great track record of coming in under budget, but Medicare […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/